Siobhán McClean

1 Introduction The development of mRNA vaccines represents a groundbreaking advancement in the field of vaccinology. They harness the body's cellular machinery to generate pathogen-specific antigens, which, in turn, induce immune responses without direct exposure to the pathogen (Zhang, Tang, et al. 2023). By 2020, mRNA vaccines had been under investigation for several decades, although they had not yet achieved widespread clinical application (Verbeke et al. 2019).

Abstract Pseudomonas aeruginosa is a frequent cause of chronic opportunistic infections in people with cystic fibrosis (CF). It is a highly diverse and adaptable Gram-negative bacterium that thrives in many environments. It is well recognised that P. aeruginosa adapts over time of colonisation to facilitate chronic infection including loss of virulence factors, however proteomic analyses of the adaptation to chronic infection have been limited.

Altmetric share Share announcement Help format_quote Cite thumb_up ... Endorse textsms ... Comment Need Help? Support Find support for a specific problem in the support section of our website. Get Support Feedback Please let us know what you think of our products and services. Give Feedback Information Visit our dedicated information section to learn more about MDPI.